Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals

Fardin Nabizadeh; Richard  T. Ward; Mohammad Balabandian; Samuel Berchi Kankam; Mahsa Pourhamzeh

doi:10.18502/cjn.v22i4.14526

Fardin Nabizadeh Neuroscience Research Group, Universal Scientific Education and Research Network, Tehran, Iran
Richard T. Ward Center for the Study of Emotion and Attention, University of Florida, Florida, USA
Mohammad Balabandian Neuroscience Research Group, Universal Scientific Education and Research Network, Tehran, Iran
Samuel Berchi Kankam School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Mahsa Pourhamzeh Division of Neuroscience, Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran

DOI: https://doi.org/10.18502/cjn.v22i4.14526

Keywords: Neurofilament Light Chain; Alzheimer's Disease; Cognitive Dysfunction; Cerebrovascular Circulation

Abstract

Background: Recent findings suggest that the plasma axonal structural protein, neurofilament light (NFL) chain, may serve as a potential blood biomarker for early signs of neurodegenerative diseases, such as Alzheimer’s disease (AD). Given the need for early detection of neurodegenerative disorders, the current study investigated the associations between regional cerebral blood flow (rCBF) in brain regions associated with neurodegenerative disorders and memory function with plasma NFL in AD, mild cognitive impairment (MCI), and healthy controls (HCs).

Methods: We recruited 29 AD, 76 MCI, and 39 HCs from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database in the current cross-sectional study. We used Pearson’s correlation models adjusted for the effect of age, sex, and APOE genotype to investigate the association between plasma NFL and rCBF.

Results: We found non-significant differences in age (F_{(2, 141)} = 1.304; P = 0.275) and years of education (F_{(2, 141)} = 0.013; P = 0.987). Additionally, we found significant differences between groups in terms of MMSE scores (F_{(2, 141)} = 100.953; P < 0.001). Despite the observation of significantly reduced rCBF in AD and MCI groups versus HCs, we did not detect significant differences in plasma NFL between these groups. We found significant negative associations between plasma NFL and rCBF in various AD-related regions, these findings were only observed after analyses in all participants, and were observed in HCs alone and no significant associations were observed in the AD or MCI groups.

Conclusion: These outcomes add to our current understanding surrounding the use of rCBF and plasma NFL biomarkers as tools for early detection and diagnosis of neurodegenerative diseases. A conclusion might be that the association between NFL and impaired rCBF exists before the clinical symptoms appear. Further longitudinal studies with a large sample size should be performed to examine the correlation between plasma NFL and rCBF in order to understand these complex relationships.